In January 2026, the Food and Drug Administration (FDA) published draft guidance that provides greater clarity regarding its authority to access and copy records related to cosmetic products marketed in the United States. This document was developed under the Modernization of Cosmetics Regulation Act (MoCRA), the most significant reform of the U.S. cosmetics industry in more than 80 years.

The publication of Regulation (EU) 2025/2650 in the Official Journal of the European Union marks a significant point in the operational evolution of the Regulation on deforestation-free products (EUDR – Regulation (EU) 2023/1115).

The publication of the Draft Guidance on mandatory cosmetic recalls by the US Food and Drug Administration represents one of the most relevant interpretative developments since the entry into force of MoCRA.

Beyond the regulatory holder, this measure will have a direct impact on formulators, importers, distributors and tattoo professionals, especially in terms of reformulation, testing, traceability and supply chain management.

The UK Department for Business and Trade (DBT) has released an update that will be particularly relevant for companies exporting cosmetic products from the United Kingdom to trans-Pacific markets. This change is linked to the UK’s accession to the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) and may reduce a common administrative burden for UK exporters.

For brands that operate in multiple markets (EU, UK, GCC, US, etc.), anticipation is key: IFRA updates often translate into reformulations , adjustments in fragrance supply, and mandatory updates to regulatory dossiers.